Last reviewed · How we verify
Sarpogrelate SR 300mg
Sarpogrelate SR 300mg is a Small molecule drug developed by Seoul National University Hospital. It is currently FDA-approved. Also known as: Anplone SR.
At a glance
| Generic name | Sarpogrelate SR 300mg |
|---|---|
| Also known as | Anplone SR |
| Sponsor | Seoul National University Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Clinical Trial to Evaluate the Efficacy and Safety of Sarpogrelate SR in Patients With Chronic Artery Occlusive Disease (PHASE4)
- Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fed Conditions (PHASE1)
- Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions (PHASE1)
- A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Fasting Conditions (PHASE1)
- A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Feeding Conditions (PHASE1)
- SAFE (Sarpogrelate Anplone in Femoro-popliteal Artery Intervention Efficacy) Study (PHASE4)
- Clinical Trial to Evaluate Efficacy and Safety of DP-R202 and Anplag in Patients With Artery Occlusive Disease (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sarpogrelate SR 300mg CI brief — competitive landscape report
- Sarpogrelate SR 300mg updates RSS · CI watch RSS
- Seoul National University Hospital portfolio CI
Frequently asked questions about Sarpogrelate SR 300mg
What is Sarpogrelate SR 300mg?
Sarpogrelate SR 300mg is a Small molecule drug developed by Seoul National University Hospital.
Who makes Sarpogrelate SR 300mg?
Sarpogrelate SR 300mg is developed and marketed by Seoul National University Hospital (see full Seoul National University Hospital pipeline at /company/seoul-national-university-hospital).
Is Sarpogrelate SR 300mg also known as anything else?
Sarpogrelate SR 300mg is also known as Anplone SR.
What development phase is Sarpogrelate SR 300mg in?
Sarpogrelate SR 300mg is FDA-approved (marketed).
Related
- Manufacturer: Seoul National University Hospital — full pipeline
- Also known as: Anplone SR
- Compare: Sarpogrelate SR 300mg vs similar drugs
- Pricing: Sarpogrelate SR 300mg cost, discount & access